We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Airway Microbiome Altered in Severe Asthma Linked to Neutrophils

By LabMedica International staff writers
Posted on 06 Jun 2019
Print article
Image: The Nextera XT Index kit is used to prepare whole genome sequencing libraries for bacterial isolates (Photo courtesy of Dr. Thippeswamy Sannasiddappa).
Image: The Nextera XT Index kit is used to prepare whole genome sequencing libraries for bacterial isolates (Photo courtesy of Dr. Thippeswamy Sannasiddappa).
Patients with mild-to-moderate asthma can experience difficulty breathing and it is especially difficult for those with Severe Asthma where symptoms can be life threatening. In either case, patients cannot participate in daily activities if their disease is uncontrolled.

As there is no single ‘gold standard’ test, clinical asthma diagnosis is based on evidence of recurrent respiratory symptoms; reversibility with anti-asthma treatment; and variable airflow obstruction. Demonstrating any or all three, of these features in a clinical setting is challenging as the disease fluctuates.

A team of scientists working with the Global Medical Franchise GSK (Brentford, UK) utilized sputum metagenomic profiling to determine if there was a relationship between neutrophilic inflammation and the airway microbiome in severe asthma. No previous metagenomic analysis has been undertaken in severe asthma to understand this relationship. Induced sputum was obtained from four cohorts as part of the U-BIOPRED study programme: (A) 97 severe asthma, non-smokers, (B) 50 severe asthma, ex/current smokers, (C) 25 steroid treated non-severe asthma and (D) 23 healthy controls.

Samples were prepared for sequencing with the Illumina Nextera kit and quantified with Quant-iT dsDNA High Sensitivity assays. Libraries were pooled and run with 100 bp paired-end sequencing protocols on the Illumina HiSeq 2500 platform., Taxonomic profiling (MetaPhlAn2), reads mapped to KEGG v75.0 (Diamond), accepting hits ≥20 amino acids with ≥80% similarity and pathway counts derived from summing the relative abundance of KOs to the pathway(s) they belong to.

The scientists reported that there were reductions in the richness and diversity between severe asthmatics and the two control cohorts. On analysis of the metagenomic profiles, taxa alpha diversity inversely correlated with sputum neutrophil percent. Veillonellaceae, Prevotellaceae, Neisseriaceae, Streptococcaceae, Porphyromonadaceae, and Micrococcaceae were all negatively correlated with percent neutrophils. Moraxellaceae was positively correlated with percent neutrophils. The team reported 67 Operational Taxonomic units (OTUs) were significantly correlated with percent neutrophils, and 65 OTUs were negatively correlated with percent neutrophils. Two OTUs: Moraxella catarrhalis and Haemophilus influenzae, were positively correlated. Thirty genes were negatively correlated with percent neutrophils. There was no correlation with sputum eosinophils.

The authors that their study associates an abnormal airway metagenomic profile in severe asthma with neutrophilic airway inflammation. Further focus is needed to better understand the dynamics of this relationship, as severe neutrophilic asthma remains an important clinically unmet need. The study was presented on May 22, 2019, at the American Thoracic Society Annual Meeting, held May 17-22, 2019, in Dallas, Texas, USA.

Related Links:
Global Medical Franchise GSK

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Ultrasonic Cleaner
UC 300 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.